Skip to Main Content

Author Details

Friedrich St??lzel
University Hospital TU Dresden
2008
131
32
PMIDPaper TitleJournal TitlePublished Year
36349721Inherited cancer predisposing mutations in patients with therapy-related myeloid neoplasms.Br J Haematol2023
37756525Germ line variant GFI1-36N affects DNA repair and sensitizes AML cells to DNA damage and repair therapy.Blood2023
37783805Ex vivo drug response profiling for response and outcome prediction in hematologic malignancies: the prospective non-interventional SMARTrial.Nat Cancer2023
37253804Long-term outcome of second allogeneic hematopoietic stem cell transplantation (HSCT2) for primary graft failure in patients with acute leukemia in remission: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.Bone Marrow Transplant2023
37386253Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).Bone Marrow Transplant2023
36978251Discriminant Principal Component Analysis of ToF-SIMS Spectra for Deciphering Compositional Differences of MSC-Secreted Extracellular Matrices.Small Methods2023
37198246Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profiles.Commun Med (Lond)2023
36480300Biallelic TET2 mutations confer sensitivity to 5'-azacitidine in acute myeloid leukemia.JCI Insight2023
36815361Impact of trisomy 19 on outcome according to genetic makeup in patients with acute myeloid leukemia.Haematologica2023
36519326A phase II, prospective, randomized, open-label study of defibrotide added to standard-of-care prophylaxis for the prevention of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.Haematologica2023
36782226GVHD occurrence does not reduce AML relapse following PTCy-based haploidentical transplantation: a study from the ALWP of the EBMT.J Hematol Oncol2023
36779591Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and <i>KIT</i> and/or <i>FLT3</i>- ITD mutations: results of the SAL MIDOKIT trial.Haematologica2023
36689727Large case-control study indicates no association of KIR genotype and risk of developing acute myeloid leukemia.Blood Adv2023
36757706Allogeneic Hematopoietic Cell Transplantation vs Standard Consolidation Chemotherapy in Patients With Intermediate-Risk Acute Myeloid Leukemia: A Randomized Clinical Trial.JAMA Oncol2023
36891455Primary Cancer Matters in Therapy-related Myeloid Neoplasm Patients Receiving Allogeneic Hematopoietic Cell Transplantation: A Study From the Chronic Malignancies Working Party of the EBMT.Hemasphere2023
36251308Next Generation Biobanking: Employing a Robotic System for Automated Mononuclear Cell Isolation.Biopreserv Biobank2023
34320176CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome.Blood2022
35617104Treosulfan compared with reduced-intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial.Am J Hematol2022
35857899Venetoclax synergizes with gilteritinib in FLT3 wild-type high-risk acute myeloid leukemia by suppressing MCL-1.Blood2022
35696192Human leukocyte antigen-haploidentical transplantation for relapsed/refractory acute myeloid leukemia: Better leukemia-free survival with bone marrow than with peripheral blood stem cells in patientsâ¿¿â¿¥55â¿¿years of age.Am J Hematol2022
35459878Allogeneic hematopoietic cell transplantation in patients with therapy-related myeloid neoplasm after breast cancer: a study of the Chronic Malignancies Working Party of the EBMT.Bone Marrow Transplant2022
35393528Augmented FLAMSA-Bu versus FluBu2 reduced-intensity conditioning in patients with active relapsed/refractory acute myeloid leukemia: an EBMT analysis.Bone Marrow Transplant2022
35752739Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT.Bone Marrow Transplant2022
35562747Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations.J Hematol Oncol2022
35747461Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donors.Ther Adv Hematol2022
36525083Fascia training in patients undergoing allogeneic hematopoietic cell transplantation-a pilot study.Support Care Cancer2022
36525083Fascia training in patients undergoing allogeneic hematopoietic cell transplantation-a pilot study.Support Care Cancer2022
36280760Correction: Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia.Bone Marrow Transplant2022
36311725Perturbations of mesenchymal stromal cells after allogeneic hematopoietic cell transplantation predispose for bone marrow graft-versus-host-disease.Front Immunol2022
36064577Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation.J Hematol Oncol2022
36258922Impaired Overall Survival in Young Patients With Acute Myeloid Leukemia and Variants in Genes Predisposing for Myeloid Malignancies.Hemasphere2022
36050938Spatial heterogeneity and differential treatment response of acute myeloid leukemia and relapsed/refractory extramedullary disease after allogeneic hematopoietic cell transplantation.Ther Adv Hematol2022
35978005Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia.Bone Marrow Transplant2022
34983928Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemia.Nat Commun2022
35033627Macroscopic, histologic, and clinical assessment of acute graft-versus-host disease of the upper gastrointestinal tract within 6 weeks after allogeneic hematopoietic cell transplantation.Exp Hematol2022
35210852Allogeneic Stem Cell Transplantation with Sequential Melphalan-Based Conditioning in AML: Residual Morphological Blast Count Determines the Risk of Relapse.Cancer Manag Res2022
34794176Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study.Blood Adv2022
34348451Characteristics and outcome of patients with core-binding factor acute myeloid leukemia and FLT3-ITD: results from an international collaborative study.Haematologica2022
33039516Long-Term Survival Benefit after Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic Leukemia.Transplant Cell Ther2021
33926021Loss-of-Function Mutations of <i>BCOR</i> Are an Independent Marker of Adverse Outcomes in Intensively Treated Patients with Acute Myeloid Leukemia.Cancers (Basel)2021
33755092A prognostic score including mutation profile and clinical features for patients with CMML undergoing stem cell transplantation.Blood Adv2021
34950586Long-Term Mixed Chimerism After <i>Ex Vivo</i>/<i>In Vivo</i> T Cell-Depleted Allogeneic Hematopoietic Cell Transplantation in Patients With Myeloid Neoplasms.Front Oncol2021
34438542Cluster Randomized Trial: Sun Protection Intervention 'Clever in Sun and Shade for Preschools'-Effectiveness and Dissemination.Children (Basel)2021
34608129Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia.Blood Cancer J2021
34543768Post-Transplantation Cyclophosphamide for Graft-versus- Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison by Donor Type. A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.Transplant Cell Ther2021
34769003Germline POT1 Deregulation Can Predispose to Myeloid Malignancies in Childhood.Int J Mol Sci2021
34594134Effective Immunosurveillance After Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia.Cancer Manag Res2021
34220922Genome-Wide Association Analyses Identify Variants in <i>IRF4</i> Associated With Acute Myeloid Leukemia and Myelodysplastic Syndrome Susceptibility.Front Genet2021
34215849Clonal hematopoiesis and its emerging effects on cellular therapies.Leukemia2021
33937079Case Report: ANXA2 Associated Life-Threatening Coagulopathy With Hyperfibrinolysis in a Patient With Non-APL Acute Myeloid Leukemia.Front Oncol2021
  • 1 - 50 of 131

Recommended Authors

Lohith Gowda
Yale Cancer Center and Yale School of Medicine
Career Start Year 2018
Number of shared co-authors 0
Justin M Watts
University of Miami, Sylvester Comprehensive Cancer Center
Career Start Year 2014
Number of shared co-authors 10
Sawa Ito
University of Pittsburgh
Career Start Year 2013
Number of shared co-authors 1
Jennifer N Saultz
Knight Cancer Institute, Oregon Health and Science University
Career Start Year 2012
Number of shared co-authors 2
Lina Benajiba
Universite de Paris, Inserm CIC 1427
Career Start Year 2009
Number of shared co-authors 7
Thomas K??hnke
Cancer Institute, Stanford University School of Medicine
Career Start Year 2008
Number of shared co-authors 3
Uma Borate
The Ohio State University
Career Start Year 2008
Number of shared co-authors 6
Courtney D DiNardo
UT MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 16
Paulo Vidal Campregher
Hospital Israelita Albert Einstein
Career Start Year 2007
Number of shared co-authors 3
Raphael Itzykson
Universite Paris Cite, INSERM, CNRS
Career Start Year 2004
Number of shared co-authors 14
Tara L Lin
University of Kansas Medical Center
Career Start Year 2004
Number of shared co-authors 5
Daniel A Pollyea
University of Colorado Division of Hematology
Career Start Year 2004
Number of shared co-authors 11
Christopher R Cogle
College of Medicine, University of Florida
Career Start Year 2003
Number of shared co-authors 3
Thomas Ernst
Universitatsklinikum Jena
Career Start Year 2002
Number of shared co-authors 6
Christopher S Hourigan
and Blood Institute, National Institutes of Health
Career Start Year 2001
Number of shared co-authors 11
Ivan Pasic
Princess Margaret Cancer Centre
Career Start Year 2001
Number of shared co-authors 0
Guillermo Garcia-Manero
MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 17
Bruno C Medeiros
AbbVie Inc.
Career Start Year 1996
Number of shared co-authors 10
David A Rizzieri
Duke University Medical Center
Career Start Year 1995
Number of shared co-authors 8
Thoralf Lange
Hospital Weissenfels
Career Start Year 1994
Number of shared co-authors 11
Gautam Borthakur
MD Anderson Cancer Center
Career Start Year 1992
Number of shared co-authors 13
Michael W Becker
James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester
Career Start Year 1992
Number of shared co-authors 1
Claude Gardin
Avicenne Hospital
Career Start Year 1990
Number of shared co-authors 8
Peter Westervelt
Washington University School of Medicine
Career Start Year 1990
Number of shared co-authors 6
Jerald P Radich
Fred Hutchinson Cancer Center
Career Start Year 1989
Number of shared co-authors 11
Daniel J DeAngelo
Dana-Farber Cancer Institute
Career Start Year 1989
Number of shared co-authors 13
Clayton A Smith
University of Colorado, Aurora CO.
Career Start Year 1987
Number of shared co-authors 2
Robert H Collins
University of Texas Southwestern Medical Center
Career Start Year 1987
Number of shared co-authors 8
Richard T Maziarz
Oregon Health & Science University
Career Start Year 1983
Number of shared co-authors 7
Martin S Tallman
Memorial Sloan-Kettering Cancer Center
Career Start Year 1982
Number of shared co-authors 14

Collaborators

Christoph R??llig
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 52
Wolfgang E Berdel
University Hospital Munster
Co-authored papers 20
Heidi Altmann
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 13
Leo Ruhnke
University Hospital Dresden
Co-authored papers 8
Nikolas von Bubnoff
University Hospital of Schleswig-Holstein
Co-authored papers 4
Michael Heuser
Hannover Medical School
Co-authored papers 4
Helena Jambor
Co-authored papers 3
Claude Preudhomme
Lille University Hospital, INSERM UMR-S7, CNRS UMR9020, Lille University.
Co-authored papers 2
Marco Prinz
Co-authored papers 2
Herv?? Dombret
Institut de Recherche Saint-Louis, Universite de Paris
Co-authored papers 2
Gordana Raca
Children's Hospital Los Angeles
Co-authored papers 2
Felicitas Thol
Hannover Medical School
Co-authored papers 2
Torsten Haferlach
Taussig Cancer Institute, Cleveland Clinic
Co-authored papers 2
Farhad Ravandi
University of Texas M.D. Anderson Cancer Center
Co-authored papers 2
Dietger Niederwieser
University of Leipzig
Co-authored papers 2
Gudrun G??hring
Hannover Medical School
Co-authored papers 2
Ulrich D??hrsen
University Hospital Essen, University of Duisburg-Essen
Co-authored papers 2
Lara E Sucheston-Campbell
The Ohio State University
Co-authored papers 2
Andrew D Skol
The University of Chicago
Co-authored papers 2
Lionel Ad??s
Assistance Publique des Hopitaux de Paris (AP-HP)
Co-authored papers 1
Julian Varghese
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 1
Stefan Hutter
University Hospital
Co-authored papers 1
Doris Steinemann
Hannover Medical School
Co-authored papers 1
John F DiPersio
Washington University School of Medicine
Co-authored papers 1
Martina Kirchner
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 1
J??rgen Klingauf
University of Munster
Co-authored papers 1
Daniel O Stram
Co-authored papers 1
Megan E McNerney
Co-authored papers 1
Lianghao Mao
German Cancer Research Center (DKFZ)
Co-authored papers 1
Hauke Busch
Co-authored papers 1
Release 1.2